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We have recently undertaken plasma exchanges on several other women sensitised to anti-D with disappointing results, despite using a more intensive regimen than that reported to be successful elsewhere.2 Our present findings suggest that the role of plasma exchange in haemolytic disease of the newborn is more complex than simply removing the antibody and that further investigations are required.
Introduction
Many techniques are used for detecting leg-vein thrombosis.' Ascending venography is the yardstick by which all others are measured but it is often uncomfortable and carries a small but definite morbidity.2 The use of fibrinogen labelled with iodine-125 avoids the problem of discomfort and has the major advantage of being performed at the bedside. It has two major disadvantages, however. Firstly, though accuracy is good in detecting calf-vein thrombosis it diminishes in the thigh,1 and the method is useless for detecting pelvic-vein thrombosis; secondly, its value lies in detecting thrombi as they form, whereas it does not accurately identify already established thrombi.
Platelets labelled with indium-11l have been used to estimate platelet survival,4-7 to diagnose renal transplant rejection,8 and in attempts to detect atherosclerotic plaques.9 10
This study was undertaken to determine whether platelets labelled with this radionuclide were useful in detecting established venous thrombosis.
Materials and methods
Platelets were labelled with indium-ill by the method of
Hawker et al.6 711 A total of 26 ml of venous blood was withdrawn with an 18-gauge needle, 9 ml being added to 1 ml 3-8% trisodium citrate and used for aggregation standards and the production of platelet-poor plasma. The remaining 17 ml was anticoagulated with 3 ml acid citrate and the platelets separated by differential centrifugation, washed, resuspended in Ca++-free Tyrode's solution containing prostaglandin E1 (Imperial Chemical Industries Ltd), and incubated with 200-250 pCi indium-ill oxine (Radiochemical Centre) at 37°C for 60 seconds. After centrifugation the platelets were suspended in 5 ml of platelet-poor plasma and reinjected into the patient 45-60 minutes after the initial venepuncture. Scanning at slow speed was performed with an El-Scint wholebody scanner fitted with medium-energy VC-3 collimators, and the data were displayed on a VD2 videoprocessing colour display. Regions of interest were imaged with an Ohio Nuclear series 410 wide-fieldof-view gammacamera linked to a Digital Equipment Corporation Gamma-1 computer system.
Ascending venography was performed on all patients after scanning was completed and the findings reported without knowledge of the results of scanning.
Results
Eight patients were studied. Ascending venography was performed on 13 legs, and five thrombi were identified in four. The number, location, and extent of these correlated precisely with the areas in which abnormal accumulations of the radiolabel had been found when the scans were interpreted. Two representative cases are described.
Case 1-A 61-year-old retired publican admitted to hospital with a three-day history of haemoptysis and left-sided pleuritic chest pain subsequently developed a pleural rub. He 
Patients and methods
Our procedure for selecting patients with mild hypertension has been described.' 2 Patients were excluded if their lying diastolic pressure fell below 90 mm Hg after a four-week outpatient run-in period with placebo. Suitable patients were then allocated in a randomised order to four treatment periods (double-blind, within-patient) of four weeks each.
Twenty-three patients were studied (12 men; average age 40 9 years, range 21-59). The drugs were taken once daily at 1800, the doses (atenolol 100 mg, sustained-release oxprenolol 160 mg, longacting propranolol 160 mg, or matching placebo) being considered to be approximately equivalent in effect.
Blood pressures were recorded with Hawksley random-zero sphygmomanometers (diastolic pressure phase 4) under standard conditions.' 2 The means of two blood-pressure readings and heart rates were recorded after five minutes' lying and two minutes' standing. A single measurement of heart rate and blood pressure was taken immediately after a two-step exercise test designed to produce a target untreated heart rate of 140/min.' 2 Measurements were made between 1400 and 1630 (20-22 hours after dosing), at the same time of day on each occasion for each patient. Patients were seen fortnightly. A questionnaire on symptoms was completed by a different observer from the one recording blood pressure.' 2 Compliance with drug taking, assessed by tablet counts, was satisfactory throughout ( > 90%).
Data on blood pressure, heart rate, and weight were analysed separately by analysis of variance after two and four weeks with each treatment. If the overall comparison between treatments, as assessed by the F test, was significant at the 5% level then pairs of adjusted means were compared using a t test. The standard deviation used in the t test was based on the residual mean square from the analysis of variance.
Results Table I lists the mean blood pressures, pulse rates, and weights during the run-in and treatment periods, and table II the levels of statistical significance.
After four weeks' treatment systolic and diastolic blood pressures measured lying, standing, and after exercise were significantly lower after atenolol and long-acting propranolol than after placebo, but the same was not true for sustained-release oxprenolol. Atenolol was significantly superior to sustained-release oxprenolol after four weeks' treatment in lowering systolic and diastolic blood pressures and heart rates in each position. Long-acting propranolol was also superior to
